Speaker: 

Deborah Siegal, MD, MSc, FRCPC Clinical Scholar, Division of Hematology and Thromboembolism, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada

Objectives: 

• Review oral anticoagulant bleeding data
• Discuss warfarin reversal
• Assess issues with DOACs and coagulation testing
• Examine DOAC reversal strategies
• Identify approach to management of DOAC bleeding

MMI Presentation: 

Hema Narayanasamy, MBBS

Locations:    

• Mayo Clinic Building, Taylor Auditorium

with video to

• Mayo Clinic Hospital, MH 1-212 and CB CC 363
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• San Tan Medical Center
• Mayo Clinic Primary Care, Phoenix Campus
• Kingman Regional Medical Center
• Canyon Ranch Medical Center

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.  

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.